583 related articles for article (PubMed ID: 25482636)
21. Coordination of VEGF receptor trafficking and signaling by coreceptors.
Nakayama M; Berger P
Exp Cell Res; 2013 May; 319(9):1340-7. PubMed ID: 23499743
[TBL] [Abstract][Full Text] [Related]
22. EphB ligand, ephrinB2, suppresses the VEGF- and angiopoietin 1-induced Ras/mitogen-activated protein kinase pathway in venous endothelial cells.
Kim I; Ryu YS; Kwak HJ; Ahn SY; Oh JL; Yancopoulos GD; Gale NW; Koh GY
FASEB J; 2002 Jul; 16(9):1126-8. PubMed ID: 12039842
[TBL] [Abstract][Full Text] [Related]
23. Mechanical strain stimulates vasculogenesis and expression of angiogenesis guidance molecules of embryonic stem cells through elevation of intracellular calcium, reactive oxygen species and nitric oxide generation.
Sharifpanah F; Behr S; Wartenberg M; Sauer H
Biochim Biophys Acta; 2016 Dec; 1863(12):3096-3105. PubMed ID: 27725190
[TBL] [Abstract][Full Text] [Related]
24. VEGFR2-dependent angiogenic capacity of pericyte-like dental pulp stem cells.
Janebodin K; Zeng Y; Buranaphatthana W; Ieronimakis N; Reyes M
J Dent Res; 2013 Jun; 92(6):524-31. PubMed ID: 23609159
[TBL] [Abstract][Full Text] [Related]
25. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells.
Gale NW; Baluk P; Pan L; Kwan M; Holash J; DeChiara TM; McDonald DM; Yancopoulos GD
Dev Biol; 2001 Feb; 230(2):151-60. PubMed ID: 11161569
[TBL] [Abstract][Full Text] [Related]
26. The impact of the receptor binding profiles of the vascular endothelial growth factors on their angiogenic features.
Nieminen T; Toivanen PI; Rintanen N; Heikura T; Jauhiainen S; Airenne KJ; Alitalo K; Marjomäki V; Ylä-Herttuala S
Biochim Biophys Acta; 2014 Jan; 1840(1):454-63. PubMed ID: 24112971
[TBL] [Abstract][Full Text] [Related]
27. Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells.
Oike Y; Ito Y; Hamada K; Zhang XQ; Miyata K; Arai F; Inada T; Araki K; Nakagata N; Takeya M; Kisanuki YY; Yanagisawa M; Gale NW; Suda T
Blood; 2002 Aug; 100(4):1326-33. PubMed ID: 12149214
[TBL] [Abstract][Full Text] [Related]
28. Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding.
Bochenek ML; Dickinson S; Astin JW; Adams RH; Nobes CD
J Cell Sci; 2010 Apr; 123(Pt 8):1235-46. PubMed ID: 20233847
[TBL] [Abstract][Full Text] [Related]
29. Ligand-Dependent and Ligand-Independent Effects of Ephrin-B2-EphB4 Signaling in Melanoma Metastatic Spine Disease.
Piffko A; Broggini T; Harms C; Adams RH; Vajkoczy P; Czabanka M
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360793
[TBL] [Abstract][Full Text] [Related]
30. Generation of transgenic mice overexpressing EfnB2 in endothelial cells.
Luxey M; Laussu J; Jungas T; Davy A
Genesis; 2011 Oct; 49(10):811-20. PubMed ID: 21735541
[TBL] [Abstract][Full Text] [Related]
31. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
32. EphrinB2-EphB4 signalling provides Rho-mediated homeostatic control of lymphatic endothelial cell junction integrity.
Frye M; Stritt S; Ortsäter H; Hernandez Vasquez M; Kaakinen M; Vicente A; Wiseman J; Eklund L; Martínez-Torrecuadrada JL; Vestweber D; Mäkinen T
Elife; 2020 Sep; 9():. PubMed ID: 32897857
[TBL] [Abstract][Full Text] [Related]
33. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
Du E; Li X; He S; Li X; He S
Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
[TBL] [Abstract][Full Text] [Related]
34. Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells.
Yang C; Guo Y; Jadlowiec CC; Li X; Lv W; Model LS; Collins MJ; Kondo Y; Muto A; Shu C; Dardik A
J Surg Res; 2013 Jul; 183(1):478-86. PubMed ID: 23394931
[TBL] [Abstract][Full Text] [Related]
35. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A
BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311
[TBL] [Abstract][Full Text] [Related]
36. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury.
Kida Y; Ieronimakis N; Schrimpf C; Reyes M; Duffield JS
J Am Soc Nephrol; 2013 Mar; 24(4):559-72. PubMed ID: 23492730
[TBL] [Abstract][Full Text] [Related]
37. Platelet-derived growth factor receptor-beta constitutive activity promotes angiogenesis in vivo and in vitro.
Magnusson PU; Looman C; Ahgren A; Wu Y; Claesson-Welsh L; Heuchel RL
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2142-9. PubMed ID: 17656670
[TBL] [Abstract][Full Text] [Related]
38. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis.
Limbourg A; Ploom M; Elligsen D; Sörensen I; Ziegelhoeffer T; Gossler A; Drexler H; Limbourg FP
Circ Res; 2007 Feb; 100(3):363-71. PubMed ID: 17234965
[TBL] [Abstract][Full Text] [Related]
39. Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion.
Marston DJ; Dickinson S; Nobes CD
Nat Cell Biol; 2003 Oct; 5(10):879-88. PubMed ID: 12973357
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development.
Chennakesava CS; Di Santo S; Ziemiecki A; Schneider H; Andres AC
Placenta; 2006; 27(9-10):959-67. PubMed ID: 16343615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]